See What Sets Us Apart

As President of CARR Biosystems, Joel Williams is responsible for driving the transformational growth agenda. Embracing the values and leadership style of the broader Barry-Wehmiller organization, he joined CARR in 2022 to build upon the growing commercial momentum of the innovative centrifuge business.

Prior to joining CARR, Joel served as the President, Pharmaceutical and Advanced Technology Business Group for ILC Dover, a leader in single-use technologies for biotherapeutic and pharma applications. Prior to ILC Dover, Joel led life sciences businesses at Avantor and Smiths Medical.

In his career, Joel has held various leadership positions in business management, sales, marketing, strategy, operations, finance, and technology development at companies including Intel, Dow Chemical, Bray International, and a Google-funded startup. Having worked and lived on three continents during that time, he brings a global perspective to CARR Biosystems.

Joel holds a Bachelor of Science degree in Mechanical Engineering from Brigham Young University, a Master of Science degree in Materials Science from the Massachusetts Institute of Technology, and a Master of Business Administration degree from Harvard Business School.

As Director of Sales for CARR Biosystems, Mike is responsible for leading the sales organization of Barry-Wehmiller’s growing centrifuge business.

Mike became the first commercial team member of CARR Separations in 1994, which was renamed CARR Biosystems in 2022. He is the originator and thought leader for the UniFuge single-use centrifuge, which was developed for the life sciences industry. Mike brings more than 35 years of life sciences experience to CARR, having developed new markets in microbial fermentation, vaccines, cell therapy, gene therapy, monoclonal antibodies, and cellular agriculture during that time.

Mike holds a Bachelor of Arts degree in Economics from
Providence College.

As VP of Operations for CARR Biosystems, Ray is directly responsible for planning, project management, engineering, assembly and fulfilment of customer orders. He has local operational responsibility for procurement, quality, customer service and sales support. Prior to this role, Ray served as the Director of Quality Assurance for CARR.

Prior to joining CARR, Ray founded VR Analytical, a cGMP testing laboratory, which became a leading provider of extractables and leachables testing for the biopharmaceutical industry. Most recently, he has served as a consultant for choice of materials used in FDA regulated industries including extractables, leachables, and chemical compatibility.

Ray holds a Master of Science degree in Chemical Engineering from University of Washington and a Master of Business Administration degree from New York University.